REFERENCES
1. L. Solomun et al., J. Pharm. Biomed. Anal. 48 (3), 744–8 (2008).
2. W. Curry et al., AAPS PharmSciTech. 11 (4), 1572–9 (2010).
3. USP 32–NF 27 (Rockville, MD, 2009), pp. 4133–4140 .
4. E.J. Smith and R.J. Nash, "Elastomeric Closures for Parenterals," in Pharmaceutical Dosage Forms: Parenteral Medications, K.E. Avis, H.A. Lieberman, L. Lachman Eds. (Marcel Dekker, New York, 1st ed., 1992), pp. 445–507.
5. G.D. Chanana, X. Guo, K.E. Avis, et al., J. Parenter. Sci. Technol. 47 (1), 22–5 (1993).
6. I. Markovic, Am. Pharm. Rev. 9 (6), 20-27 (2006).
7. D.R. Jenke, PDA J. Pharm. Sci. Technol. 59 (4), 265–281 (2005)
8. FDA Container and Closure Integrity Testing in Lieu of Sterility Testing as a Component of the Stability Protocol for Sterile
Products, (Rockville, MD, Feb. 2008).
9. L.S. Burrell, M.W. Carver, G.E. DeMuth, and W.J. Lambert, PDA J, Pharm. Sci. Technol. 54 (6), 449–55 (2000).
10. E. Kirsch et al., PDA J, Pharm. Sci. Technol. 51 (5), 195–202 (1997).
11. P. Kiang et al., J. Parenter. Sci. Technol. 46 (S2) (1992).
|
